TrialJournal of translational medicine2010

The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.

Maximilian Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.